Salomon & Ludwin
ANIP icon

Salomon & Ludwin’s ANI Pharmaceuticals ANIP Stock Holding History

Salomon & Ludwin’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.5K Sell
186
-62
-25% -$4.77K ﹤0.01% 1179
2026
Q2 		$20.6K Sell
248
-53
-18% -$4.25K ﹤0.01% 1126
2026
Q1 		$22.3K Buy
301
+136
+82% +$10.6K ﹤0.01% 1008
2025
Q4 		$13K Buy
165
+41
+33% +$3.55K ﹤0.01% 1259
2025
Q3 		$11.1K Buy
+124
New +$10.1K ﹤0.01% 1232

Other funds holding ANIP

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Ranger Investment Management
Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Mizuho Markets Americas
Mizuho Markets Americas New York $6.82B AUM 29.92% 1-Year Est. Return
Penn Capital Management
Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Salomon & Ludwin's ANIP Position: Q3 2026 in Review

Salomon & Ludwin reduced its ANI Pharmaceuticals (ANIP) stake by 25% in Q3 2026, selling an estimated $4.77K and leaving 186 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1179.

Salomon & Ludwin first reported a position in ANIP in Q3 2025 and has held it in 5 quarters since. The position peaked at $22.3K in Q1 2026. 125 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • Salomon & Ludwin held 186 shares of ANI Pharmaceuticals worth $13.5K as of Q3 2026.
  • Salomon & Ludwin sold 62 ANI Pharmaceuticals shares in Q3 2026, an estimated $4.77K.
  • ANI Pharmaceuticals made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #1179 holding.
  • Salomon & Ludwin first reported a position in ANI Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Salomon & Ludwin's ANI Pharmaceuticals position peaked at $22.3K in Q1 2026.
  • 125 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.